Latest HUM news and sentiment

Humana's pharmacy brand CenterWell enters a distribution deal with TempraMed.

TempraMed Technologies (TMPTF) has signed a distribution agreement with CenterWell Pharmacy, Humana's pharmacy services brand, to distribute its temperature-sensitive medication storage solutions in the United States. The deal, dated August 25, 2026, aims to expand TempraMed's commercial presence and ensure the proper management of life-saving medications. TempraMed develops FDA-registered thermal-insulation devices that operate without batteries or external power.

OIG: Humana, UnitedHealthcare upcoded MA claims by $180M | Cigna's $3M dispute over No Surprises Act reimbursement

An HHS-OIG audit found that Humana and UnitedHealthcare allegedly upcoded Medicare Advantage claims by $180 million, though the payers deny wrongdoing and are not obligated to repay. Simultaneously, a federal judge declined to intervene in Cigna's refusal to pay a $3 million No Surprises Act award, stating that courts cannot compel such payments under the Act's provisions. The article also highlights other significant healthcare news including new appointments to the Preventive Services Task Force and a lawsuit against Express Scripts.

Nykredit A S Makes New $12.46 Million Investment in Humana Inc. $HUM

Nykredit A S has made a new investment of $12.46 million in Humana Inc. (NYSE:HUM) by purchasing 31,361 shares during the second quarter. This move is part of broader institutional interest, with other major investors like BlackRock Inc. and Pzena Investment Management LLC also adjusting their stakes in Humana. The article also details recent analyst ratings, Humana's price performance, earnings, and dividend announcements.

Other financing cash flow items (total) of Humana Inc. – NYSE:HUM

This article provides financial data specifically on "Other financing cash flow items (total)" for Humana Inc. (NYSE: HUM). It indicates that the market is closed, with no trades, and offers a brief overview of the company's financial information within the TradingView platform. The content primarily focuses on presenting this specific financial metric over different periods.

New Humana research finds association between pharmacy care coordination services and improved health outcomes for cancer patients

Study published in the Expert Review of Pharmacoeconomics & Outcomes Research LOUISVILLE, Ky., September 17, 2026--(BUSINESS WIRE)--A new study published in the Expert Review of Pharmacoeconomics & Outcomes Research finds that engagement with a dedicated team of specialty pharmacy care coordinators was associated with improved health outcomes among cancer patients, including fewer hospitalizations and emergency department visits. In tandem, that engagement also was associated with lower medical costs. Titled "The Impact of Clinical Pharmacy Services Within an Oncology Center of Excellence on P

Humana Community Day 2026 Generates 2.2 Million Meals and Community Investments Nationwide

More than 18,000 Humana employees joined nonprofit partners across the country to improve community health, demonstrating how a single day of service can create lasting local impact. LOUISVILLE, Ky., September 16, 2026--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company's annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200nonprofit organizations, and positively impacted 2.25 million lives and community members through volunteer

CLOV Stock Hits Over 2-Month High As Humana Deal Buzz Builds Ahead Of Investor Conferences

BofA Adjusts Price Target on Humana to $510 From $500

Humana is dropping hundreds of thousands of Medicare Advantage plans. Is one of them yours?

Humana announced it will drop hundreds of thousands of Medicare Advantage plans, impacting approximately 600,000 members as the company prioritizes higher-performing plans. Members potentially affected by these changes should look for an annual notice of change between September 15th and October 15th, and prepare to select a new plan during the annual election period from October 15th to December 7th. Affected individuals are advised to contact their doctors about accepted plans, use Medicare.gov, or consider a standard Medicare plan with Medigap insurance.

Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?

On August 11, Humana Inc. (NYSE:HUM) announced that its Medicaid plan, Humana Healthy Horizons in Indiana, is collaborating with HealthStream, Inc. (NASDAQ:HSTM). The partnership expands access to workforce training for caregivers, aiming to recruit and retain talent in rural and underserved communities. While one provides healthcare coverage and the other builds the software to train healthcare workers, both companies are capitalizing on the industry's critical focus: solving caregiving shortages and optimizing healthcare delivery.Is AbbVie Inc. (ABBV)’s $10.9 Billion Apogee Therapeutics, Inc

Humana sues Bayer over unpaid medical liens in Roundup settlements

Humana is suing Bayer, alleging that the pharmaceutical giant failed to reimburse the insurer for medical expenses paid on behalf of Medicare Advantage members who settled Roundup claims. The lawsuit seeks double damages, focusing on the proposed $7.25 billion class settlement related to Bayer's Roundup weedkiller. Humana claims these settlements were made without the health plan being repaid for the members' medical costs.

Is Humana Stock Outperforming the Dow?

Humana corporate headquarters_ Humana is a for-profit health insurance company_ By jetcityimage Humana Inc. (HUM) is a Louisville, Kentucky-based health and well-being company that primarily serves seniors through Medicare Advantage and prescription drug plans. It operates two segments: Insurance, which administers government-contracted medical benefits for millions of members, and CenterWell, a senior-focused care platform offering primary care, pharmacy, and home health services. With a market capitalization of $48.40 billion, the company is considered a "big cap" stock. Humana's stock reach

Is Humana Stock Outperforming the Dow?

Amundi Has $154.51 Million Stock Position in Humana Inc. $HUM

Amundi reduced its stake in Humana Inc. by 14.6% in the second quarter, now owning 388,972 shares valued at $154.51 million. Other institutional investors, including California State Teachers Retirement System and HighTower Advisors LLC, have also adjusted their positions in the insurance provider. Humana's stock recently opened at $403.08, has a market cap of $48.40 billion, and analysts have a consensus "Hold" rating with a target price of $403.91.

How Humana Inc. (HUM) Affects Rotational Strategy Timing

This article analyzes Humana Inc. (HUM) through a rotational strategy timing lens, highlighting a strong overweight bias across all horizons. It identifies a mid-channel oscillation pattern and a significant risk-reward short setup. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for near-term, mid-term, and long-term outlooks.

Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition

Humana Inc. has received the 2026 Great Place To Work Certification™ for the fifth consecutive year and has again been named to the PEOPLE Companies That Care® list. These recognitions highlight Humana's dedication to fostering a supportive workplace culture, with 79% of employees considering it a great place to work. The company's commitment extends to community involvement, employee well-being, and professional development, driven by its 41,600 employees.

Cantor Fitzgerald reiterates Humana stock rating at Neutral

Cantor Fitzgerald has reiterated a Neutral rating on Humana Inc. (NYSE:HUM) stock, noting challenges in managing a large 1.5 million-life contract across 50 states and expressing skepticism about readily accepting Humana's bullish performance commentary without public data. Despite the neutral rating, Humana's stock trades near its 52-week high, and the company has been the subject of several recent upgrades and price target increases from other firms due to optimism about its Medicare Advantage margin improvements and earnings recovery goals. The article also mentions a recent legal settlement where Glenmark Pharmaceuticals' U.S. unit settled an antitrust case with Humana for $15.3 million.

For 4 Years, The Villages’ Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million.

Quick Read By 2024, half of The Villages Health's diagnosis codes were unsupported, resulting in a $541.5 million Medicare fraud settlement involving Humana (HUM). The settlement targets the bankrupt pre-sale entity, shielding CenterWell and Humana from direct payment while the government holds a nondischargeable bankruptcy claim. The DOJ resolved three Medicare Advantage upcoding cases in one month, signaling risk-adjustment fraud has become a federal enforcement priority. Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now. The report is